- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02138279
Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements
June 6, 2022 updated by: Topcon Medical Systems, Inc.
Comparative Study of the Topcon Tonometers - CT-800, CT-1, CT-1P and TRK-2P to Demonstrate Conformance to ANSI Z80.10-2009 Ophthalmic Instruments -Tonometers, to the FDA Guidance for Industry and FDA Staff, Tonometer-Premarket Notification [510(k)] Submissions, and to the Applicable Supplemental Information Sheet and Comparison of Pachymetry Values for CT-1P and TRK-2P With the Konan CellChek Plus (Predicate)
The primary objective of this clinical study is to collect clinical data to support FDA 510(k) submissions for the Topcon CT-800, CT-1, CT-1P and TRK-2P non-contact tonometers.
The secondary objective is to evaluate any adverse events found during the clinical study.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
65
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Andover, Massachusetts, United States, 01810
- Andover Eye Associates
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Ophthalmology practice
Description
Inclusion Criteria:
- At least 18 years of age of either sex and any race or ethnicity;
- Willing and able to provide written informed consent prior to any study procedures being performed;
- Willing and able to follow all instructions and attend all study visits;
- Best Spectacle Corrected Visual Acuity (BSCVA) of 0.3 logMAR (20/40 Snellen equivalent) or better in both eyes as measured using an ETDRS chart.
Exclusion Criteria:
- Only one functional eye;
- Poor or eccentric fixation;
- Corneal scarring or have had corneal surgery, including corneal laser surgery;
- Microphthalmos;
- Buphthalmos;
- Contact lens wearer, meaning having worn soft contact lenses within the past 3 months and/or rigid permeable gas lenses within the past 6 months;
- Dry eyes, meaning having been diagnoses by a physician with dry eyes and currently using a prescribed medication;
- Lid squeezer - blepharospasm;
- Nystagmus;
- Keratoconus;
- Any other corneal or conjunctival pathology or infection;
- Condition or a situation, which in the Investigator's opinion, may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Male and female adults 18+ years of age
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Agreement of intraocular pressure measurements from predicate vs. investigational device
Time Frame: Single timepoint - 1 day
|
Single timepoint - 1 day
|
|
Agreement of central corneal thickness measurements from predicate vs. investigational device
Time Frame: Single time point - 1 day
|
Single time point - 1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
July 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
April 23, 2014
First Submitted That Met QC Criteria
May 12, 2014
First Posted (Estimate)
May 14, 2014
Study Record Updates
Last Update Posted (Actual)
June 8, 2022
Last Update Submitted That Met QC Criteria
June 6, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- TOPCON-TON-US-0001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraocular Pressure
-
Uşak UniversityRecruitingIntraocular PressureTurkey (Türkiye)
-
CHU de Quebec-Universite LavalRecruiting
-
University of PittsburghRecruiting
-
Nidek Co. LTD.CompletedIntraocular Pressure
-
Research Insight LLCCompletedIntraocular PressureUnited States
-
Icare Finland OyCompleted
-
The University of Hong KongCompleted
-
Rajiv Gandhi Cancer Institute & Research Center...CompletedIntraocular PressureIndia